Morgan Stanley’s Black Diamond Therapeutics BDTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $224K | Sell |
90,318
-334,042
| -79% | -$828K | ﹤0.01% | 5805 |
|
|
2025
Q1 | $658K | Buy |
424,360
+206,340
| +95% | +$320K | ﹤0.01% | 5206 |
|
|
2024
Q4 | $467K | Buy |
218,020
+93,016
| +74% | +$199K | ﹤0.01% | 5442 |
|
|
2024
Q3 | $544K | Sell |
125,004
-91,324
| -42% | -$397K | ﹤0.01% | 5364 |
|
|
2024
Q2 | $1.01M | Buy |
216,328
+157,430
| +267% | +$734K | ﹤0.01% | 4956 |
|
|
2024
Q1 | $299K | Buy |
58,898
+35,236
| +149% | +$179K | ﹤0.01% | 5563 |
|
|
2023
Q4 | $66.5K | Buy |
23,662
+1,611
| +7% | +$4.53K | ﹤0.01% | 6295 |
|
|
2023
Q3 | $63.3K | Buy |
22,051
+5,782
| +36% | +$16.6K | ﹤0.01% | 6066 |
|
|
2023
Q2 | $82.2K | Sell |
16,269
-11,705
| -42% | -$59.1K | ﹤0.01% | 6029 |
|
|
2023
Q1 | $52.9K | Sell |
27,974
-3,228
| -10% | -$6.1K | ﹤0.01% | 6269 |
|
|
2022
Q4 | $56.2K | Sell |
31,202
-197,987
| -86% | -$356K | ﹤0.01% | 6240 |
|
|
2022
Q3 | $387K | Sell |
229,189
-307,031
| -57% | -$518K | ﹤0.01% | 5392 |
|
|
2022
Q2 | $1.32M | Buy |
536,220
+42,858
| +9% | +$105K | ﹤0.01% | 4832 |
|
|
2022
Q1 | $1.37M | Sell |
493,362
-280,574
| -36% | -$777K | ﹤0.01% | 4780 |
|
|
2021
Q4 | $4.13M | Buy |
773,936
+12,845
| +2% | +$68.5K | ﹤0.01% | 3917 |
|
|
2021
Q3 | $6.44M | Buy |
761,091
+160,071
| +27% | +$1.35M | ﹤0.01% | 3412 |
|
|
2021
Q2 | $7.33M | Buy |
601,020
+588,232
| +4,600% | +$7.17M | ﹤0.01% | 3361 |
|
|
2021
Q1 | $311K | Sell |
12,788
-98,873
| -89% | -$2.4M | ﹤0.01% | 5400 |
|
|
2020
Q4 | $3.58M | Buy |
111,661
+103,150
| +1,212% | +$3.31M | ﹤0.01% | 3622 |
|
|
2020
Q3 | $257K | Buy |
8,511
+4,695
| +123% | +$142K | ﹤0.01% | 4974 |
|
|
2020
Q2 | $161K | Buy |
3,816
+2,406
| +171% | +$102K | ﹤0.01% | 5179 |
|
|
2020
Q1 | $35K | Buy |
+1,410
| New | +$35K | ﹤0.01% | 5588 |
|